Alcohol and Alcoholism Advance Access published online on September 18, 2007
Alcohol and Alcoholism, doi:10.1093/alcalc/agm062
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compliance with Aftercare Treatment, Including Disulfiram, and Effect on Outcome in Alcohol-Dependent Patients
Centro Regional de Alcoologia do Sul, CRAS, Parque de Saúde de Lisboa, Av. do Brasil, 53 A. 1749-006 Lisbon, Portugal
* Author to whom correspondence should be addressed at: Centro Regional de Alcoologia do Sul, CRAS, Parque de Saúde de Lisboa, Av. do Brasil, 53 A. 1749-006 Lisbon, Portugal. Tel: +351 21 7961807; +351 21 7958030; Fax: +351 21 7940427; E-mail: dneto{at}mail.telepac.pt
Received 23 January 2007; first review notified 26 June 2007; ; accepted 2 July 2007
 |
Abstract |
|---|
Aim: To delineate the features of treatment compliance with which predicted outcome during aftercare treatment in a series of patients that completed an inpatient program at the Lisbon Regional Alcohology Centre (CRAS). Methods: Seventy-four alcohol dependent patients, sequentially admitted to the inpatient treatment of CRAS, were followed over 6 months after discharge. This study focused on the predictive value of the aftercare therapies, which included: attending Alcoholics Anonymous (AA) meetings, attending aftercare groups (AG), attending outpatient consultations with the medical assistant. Disulfiram was prescribed to 83.3% of the patients. At the end of the 6-months follow-up period, the patients and their ‘significant others’ (co-responsible persons) were interviewed on the telephone by an independent interviewer. The data collected for analysis consists of information from the interviews, and also of data from the patient clinical files. Results: Survival analysis revealed that, after 6 months of follow-up, 39.2% of the patients had attained total abstinence of alcohol ingestion; 71% of the relapses on alcohol consumption occurred within the first 3 months. The median number of days taking disulfiram was significantly related to the number of days of abstinence. Demographic variables, pre-treatment variables, attendance at AA meetings, AGs and outpatient appointments were not significant predictors of outcome. Conclusions: Consistently taking disulfiram is associated with good outcome, but this may reflect committment to abstinence as well as a treatment effect.